Back

Automated continuous rhythm monitoring with implantable cardiac monitor and real-time smartphone alerts during af episodes: SMART-ALERT study

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: clinical Stroke Prevention EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Timothy Betts

Oxford University Hospitals NHS Trust, Oxford (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Is thyroid function testing necessary in all cases of new onset atrial fibrillation diagnosed in the emergency department? - a real-life study
Doctor J. Hytting (Norrkoping, SE)
Abstract Slides Video
Presentation thumbnail
Effects of sodium glucose co-transporter-2 inhibitor on atrial tachyarrhythmia burden in patients with cardiovascular implantable electronic device
Assistant Professor T. Nantsupawat (Chiang Mai, TH)
Abstract Slides Video
Presentation thumbnail
Comparison between Novel and Conventional Electrocardiographic Markers of Atrial Cardiomyopathy for identification of Persons at Risk for Ischemic Stroke
Professor A. Jadidi (Luzern, CH)
Abstract Slides Video
Presentation thumbnail
Incidence and outcome of periinterventional atrial fibrillation in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention
Mr J. Jost (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Early rhythm control in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III
Doctor B. Corica (Modena, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: clinical

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
SMART-ALERT study: continuous cardiac monitoring and real-time automated smartphone alerts for atrial fibrillation episodes
thumbnail
Congress Presentation
Smartphone application for improving self-awareness of adherence to edoxaban treatment: a randomised controlled trial (ADHERE-APP)
thumbnail
Congress Presentation
Smart Study, a clinical future for accessible smart technology

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources